Platelet aggregation was assessed by light transmission aggregometry in a PAP‐8E (Bio/Data Corporation) aggregometer for up to 30 min. Washed platelets were incubated with aPT antibodies for 5 min with an antiprothrombin antibody (50 μg/ml) followed by CaCl2 (1 mM, 3 mM, or 10 mM) and purified human prothrombin (1 µM). In some studies, platelets were preincubated with eptifibatide (9 µM), vorapaxar (1 µM) + BMS‐986120 (1 µM), indomethacin (10 µM), ticagrelor (10 µM), PRT‐060318 (5 µM), dasatinib (10 µM), mAb IV.3 (10 µg/ml), or rivaroxaban (200, 400, 800, or 1000 nM) for 10 min.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.